421 related articles for article (PubMed ID: 29524841)
21. In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity.
Chen CT; Wang ZH; Hsu CC; Lin HH; Chen JH
Nutrients; 2015 Jun; 7(6):4938-54. PubMed ID: 26091236
[TBL] [Abstract][Full Text] [Related]
22. miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice.
Hu X; Liu H; Wang Z; Hu Z; Li L
Oxid Med Cell Longev; 2019; 2019():1512326. PubMed ID: 31781322
[TBL] [Abstract][Full Text] [Related]
23. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
24. Dioscin alleviates dimethylnitrosamine-induced acute liver injury through regulating apoptosis, oxidative stress and inflammation.
Zhang W; Yin L; Tao X; Xu L; Zheng L; Han X; Xu Y; Wang C; Peng J
Environ Toxicol Pharmacol; 2016 Jul; 45():193-201. PubMed ID: 27317992
[TBL] [Abstract][Full Text] [Related]
25. Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling.
Cheng X; Liu D; Xing R; Song H; Tian X; Yan C; Han Y
Biomed Res Int; 2020; 2020():5923572. PubMed ID: 33134382
[TBL] [Abstract][Full Text] [Related]
26. Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
Zhang WB; Lai X; Guo XF
Oxid Med Cell Longev; 2021; 2021():8860883. PubMed ID: 33574984
[TBL] [Abstract][Full Text] [Related]
27. [Hesperetin Alleviates Doxorubicin-Induced Cytotoxicity in H9c2 Cells by Activating SIRT1/NRF2 Signaling].
Li X; Yan A; Chang J; Li F; Zhu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):947-953. PubMed ID: 37866951
[TBL] [Abstract][Full Text] [Related]
28. Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro.
Wang C; Hu L; Guo S; Yao Q; Liu X; Zhang B; Meng X; Yang X
Toxicology; 2021 Aug; 460():152881. PubMed ID: 34358621
[TBL] [Abstract][Full Text] [Related]
29. MiR-125b enhances doxorubicin-induced cardiotoxicity by suppressing the nucleus-cytoplasmic translocation of YAP via targeting STARD13.
Jin X; Yu W; Ye P
Environ Toxicol; 2022 Apr; 37(4):730-740. PubMed ID: 34921586
[TBL] [Abstract][Full Text] [Related]
30. Protective Effects of
Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-31-5p attenuates doxorubicin-induced cardiotoxicity via quaking and circular RNA Pan3.
Ji X; Ding W; Xu T; Zheng X; Zhang J; Liu M; Liu G; Wang J
J Mol Cell Cardiol; 2020 Mar; 140():56-67. PubMed ID: 32135167
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
[TBL] [Abstract][Full Text] [Related]
35. Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity.
Xu F; Li X; Xiao X; Liu LF; Zhang L; Lin PP; Zhang SL; Li QS
Biomed Pharmacother; 2017 Nov; 95():504-512. PubMed ID: 28866417
[TBL] [Abstract][Full Text] [Related]
36. Crocin protects against cardiotoxicity induced by doxorubicin through TLR-2/NF-κB signal pathway in vivo and vitro.
Chu X; Zhang Y; Xue Y; Li Z; Shi J; Wang H; Chu L
Int Immunopharmacol; 2020 Jul; 84():106548. PubMed ID: 32388215
[TBL] [Abstract][Full Text] [Related]
37. Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats.
Zhang YY; Yi M; Huang YP
Cell Physiol Biochem; 2017; 43(2):626-635. PubMed ID: 28946137
[TBL] [Abstract][Full Text] [Related]
38. Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway.
Wu YZ; Zhang L; Wu ZX; Shan TT; Xiong C
Oxid Med Cell Longev; 2019; 2019():2150394. PubMed ID: 31885776
[TBL] [Abstract][Full Text] [Related]
39. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling.
Ye M; Zhang L; Yan Y; Lin H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation.
Qiao Y; Xu L; Tao X; Yin L; Qi Y; Xu Y; Han X; Tang Z; Ma X; Liu K; Peng J
Toxicol Lett; 2018 Mar; 284():37-45. PubMed ID: 29197622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
